37
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Loss-of-function mutations in the X-linked biglycan gene cause a severe syndromic form of thoracic aortic aneurysms and dissections

      research-article
      , MSc 1 , , PhD 1 , , PhD 2 , , MD, PhD 3 , 1 , 1 , , MD 4 , , MD 4 , , MD 5 , , MD 6 , , MD 7 , , MD 8 , , MD 9 , , MD 9 , , MD 10 , 11 , , MSc 1 , , MD 12 , 13 , , PhD 1 , , MD, PhD 1 , , PhD 1 , , PhD 1 , , MD, PhD 1
      Genetics in medicine : official journal of the American College of Medical Genetics
      Biglycan, BGN, Thoracic aortic aneurysm, Genetics, Marfan Syndrome, Loeys-Dietz Syndrome

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Purpose

          Thoracic aortic aneurysm and dissection (TAAD) is typically inherited in an autosomal dominant manner, but rare X-linked families have been described. So far the only known X-linked gene is FLNA, which is associated with the periventricular nodular heterotopia type of Ehlers-Danlos syndrome. However, mutations in this gene only explain a small number of X-linked TAAD families.

          Methods

          We performed targeted resequencing of 368 candidate genes in a cohort of 11 molecularly unexplained Marfan probands. Subsequently, Sanger sequencing of BGN in 360 male and 155 female molecularly unexplained TAAD probands was carried out.

          Results

          We found five individuals with loss-of-function mutations in BGN, encoding the small leucine-rich proteoglycan biglycan. The clinical phenotype is characterized by early onset aortic aneurysm and dissection. Other recurrent findings include hypertelorism, pectus deformity, joint hypermobility, contractures and mild skeletal dysplasia. Fluorescent stainings revealed an increase in TGF-β signalling, evidenced by an increase in nuclear pSMAD2 in aortic wall. Our results are in line with prior reports demonstrating that Bgn-deficient male BALB/cA mice die from aortic rupture.

          Conclusion

          In conclusion, BGN gene defects in humans cause an X-linked syndromic form of severe TAAD, associated with preservation of elastic fibres and increased TGF-β signalling.

          Related collections

          Most cited references35

          • Record: found
          • Abstract: found
          • Article: not found

          Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta.

          We have analysed the interactions of three proteoglycans of the decorin family, decorin, biglycan and fibromodulin, with transforming growth factor beta (TGF-beta). The proteoglycan core proteins, expressed from human cDNAs as fusion proteins with Escherichia coli maltose-binding protein, each bound TGF-beta 1. They showed only negligible binding to several other growth factors. Intact decorin, biglycan and fibromodulin isolated from bovine tissues competed with the fusion proteins for the TGF-beta binding. Affinity measurements suggest a two-site binding model with Kd values ranging from 1 to 20 nM for a high-affinity binding site and 50 to 200 nM for the lower-affinity binding site. The stoichiometry indicated that the high-affinity binding site was present in one of ten proteoglycan core molecules and that each molecule contained a low-affinity binding site. Tissue-derived biglycan and decorin were less effective competitors for TGF-beta binding than fibromodulin or the non-glycosylated fusion proteins; removal of the chondroitin/dermatan sulphate chains of decorin and biglycan (fibromodulin is a keratan sulphate proteoglycan) increased the activities of decorin and biglycan, suggesting that the glycosaminoglycan chains may hinder the interaction of the core proteins with TGF-beta. The fusion proteins competed for the binding of radiolabelled TGF-beta to Mv 1 Lu cells and endothelial cells. Affinity labelling showed that the binding of TGF-beta to betaglycan and the type-I receptors in Mv 1 Lu cells and to endoglin in endothelial cells was reduced, but the binding to the type-II receptors was unaffected. TGF-beta 2 and 3 also bound to all three fusion proteins. Latent recombinant TGF-beta 1 precursor bound slightly to fibromodulin and not at all to decorin and biglycan. The results show that the three decorin-type proteoglycans each bind TGF-beta isoforms and that slight differences exist in their binding properties. They may regulate TGF-beta activities by sequestering TGF-beta into extracellular matrix.
            • Record: found
            • Abstract: found
            • Article: not found

            Lessons on the pathogenesis of aneurysm from heritable conditions.

            Aortic aneurysm is common, accounting for 1-2% of all deaths in industrialized countries. Early theories of the causes of human aneurysm mostly focused on inherited or acquired defects in components of the extracellular matrix in the aorta. Although several mutations in the genes encoding extracellular matrix proteins have been recognized, more recent discoveries have shown important perturbations in cytokine signalling cascades and intracellular components of the smooth muscle contractile apparatus. The modelling of single-gene heritable aneurysm disorders in mice has shown unexpected involvement of the transforming growth factor-β cytokine pathway in aortic aneurysm, highlighting the potential for new therapeutic strategies.
              • Record: found
              • Abstract: found
              • Article: not found

              Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues.

              The messenger RNAs and core proteins of the two small chondroitin/dermatan sulfate proteoglycans, biglycan and decorin, were localized in developing human bone and other tissues by both 35S-labeled RNA probes and antibodies directed against synthetic peptides corresponding to nonhomologous regions of the two core proteins. Biglycan and decorin expression and localization were substantially divergent and sometimes mutually exclusive. In developing bones, spatially restricted patterns of gene expression and/or matrix localization of the two proteoglycans were identified in articular regions, epiphyseal cartilage, vascular canals, subperichondral regions, and periosteum, and indicated the association of each molecule with specific developmental events at specific sites. Study of non-skeletal tissues revealed that decorin was associated with all major type I (and type II) collagen-rich connective tissues. Conversely, biglycan was expressed and localized in a range of specialized cell types, including connective tissue (skeletal myofibers, endothelial cells) and epithelial cells (differentiating keratinocytes, renal tubular epithelia). Biglycan core protein was localized at the cell surface of certain cell types (e.g., keratinocytes). Whereas the distribution of decorin was consistent with matrix-centered functions, possibly related to regulation of growth of collagen fibers, the distribution of biglycan pointed to other function(s), perhaps related to cell regulation.

                Author and article information

                Journal
                9815831
                22061
                Genet Med
                Genet. Med.
                Genetics in medicine : official journal of the American College of Medical Genetics
                1098-3600
                1530-0366
                9 August 2016
                15 September 2016
                15 March 2017
                : 10.1038/gim.2016.126
                Affiliations
                [1 ]Center of Medical Genetics, University of Antwerp and Antwerp University Hospital, Antwerp, 2650, Belgium
                [2 ]Department of Cell Biology and Histology, University of Antwerp, Antwerp, 2020, Belgium
                [3 ]Department of Pathology, University Hospital Antwerp, University of Antwerp, Antwerp, 2610, Belgium
                [4 ]Department of Pediatric Cardiology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, 60015, USA
                [5 ]Divisions of Pediatric and Adult Cardiology, Vanderbilt University, Nashville, TN, 37232, USA
                [6 ]West Midlands Regional Genetics Service, Birmingham Women’s NHS Foundation Trust, Birmingham, B15 2TG, United Kingdom
                [7 ]Department of Medical Genetics, Children’s Hospital of Eastern Ontario, Ottawa, ON, K1H 8L1, Canada
                [8 ]Division of Cardiology, University of Ottawa Heart Institute, Ottawa, ON, K1Y 4W7, Canada
                [9 ]Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois, Lausanne, 1011, Switzerland
                [10 ]Department of Pediatrics, Centre Hospitalier Universitaire Vaudois, Lausanne, 1011, Switzerland
                [11 ]The Heart Unit, Birmingham Children’s Hospital, Birmingham, B4 6NH, United Kingdom
                [12 ]Howard Hughes Medical Institute, Baltimore, MD, 21205, USA
                [13 ]McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA
                Author notes
                Correspondence: Bart L. Loeys ( bart.loeys@ 123456uantwerpen.be )
                Article
                EMS69470
                10.1038/gim.2016.126
                5207316
                27632686
                a1bfc1fa-01f3-4d3c-a9af-d8bb8612a7a8

                Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms

                History
                Categories
                Article

                Genetics
                biglycan,bgn,thoracic aortic aneurysm,genetics,marfan syndrome,loeys-dietz syndrome
                Genetics
                biglycan, bgn, thoracic aortic aneurysm, genetics, marfan syndrome, loeys-dietz syndrome

                Comments

                Comment on this article

                Related Documents Log